Ainos (AIMD) Stock Overview
A dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
AIMD Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Ainos, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3.95 |
| 52 Week High | US$5.00 |
| 52 Week Low | US$2.00 |
| Beta | 2.27 |
| 1 Month Change | 16.86% |
| 3 Month Change | 32.55% |
| 1 Year Change | 58.06% |
| 3 Year Change | -88.87% |
| 5 Year Change | -94.15% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Ainos (NASDAQ:AIMD) Is Carrying A Fair Bit Of Debt
Aug 29
We Think Ainos (NASDAQ:AIMD) Has A Fair Chunk Of Debt
Mar 10Here's Why Ainos (NASDAQ:AIMD) Can Afford Some Debt
Aug 28Here's Why Ainos (NASDAQ:AIMD) Can Afford Some Debt
May 15Ainos rises 50% on positive data from animal study trial of Veldona to treat COVID-19
Sep 30Ainos stock rises on FDA filing for starting phase 2 trial of Veldona for COVID-19
Aug 24Amarillo Biosciences GAAP EPS of -$0.01, revenue of $636.62M
Aug 15Shareholder Returns
| AIMD | US Tech | US Market | |
|---|---|---|---|
| 7D | 10.0% | -1.0% | 0.3% |
| 1Y | 58.1% | 12.5% | 17.3% |
Return vs Industry: AIMD exceeded the US Tech industry which returned 14% over the past year.
Return vs Market: AIMD exceeded the US Market which returned 17.8% over the past year.
Price Volatility
| AIMD volatility | |
|---|---|
| AIMD Average Weekly Movement | 14.8% |
| Tech Industry Average Movement | 8.7% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 17.3% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AIMD's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: AIMD's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 44 | Chun-Hsien Tsai | www.ainos.com |
Ainos, Inc., a dual-platform AI and biotech company, focusing SmellTech, AI diagnostics, and immune therapeutics. Its AI Nose platform uses a smell language model to digitize scent into Smell IDs and turning invisible chemical signals into machine-readable data. The company is also giving AI for robotics, smart factories, senior care, and women’s health.
Ainos, Inc. Fundamentals Summary
| AIMD fundamental statistics | |
|---|---|
| Market cap | US$19.08m |
| Earnings (TTM) | -US$15.72m |
| Revenue (TTM) | US$110.87k |
Is AIMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AIMD income statement (TTM) | |
|---|---|
| Revenue | US$110.87k |
| Cost of Revenue | US$19.64k |
| Gross Profit | US$91.23k |
| Other Expenses | US$15.82m |
| Earnings | -US$15.72m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.30 |
| Gross Margin | 82.29% |
| Net Profit Margin | -14,182.68% |
| Debt/Equity Ratio | 96.1% |
How did AIMD perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/09 20:38 |
| End of Day Share Price | 2025/10/09 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ainos, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.